Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular therapy

A W Flake1, E D Zanjani

  • 1Children's Hospital of Philadelphia, Pennsylvania, USA.

Obstetrics and Gynecology Clinics of North America
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Prenatal transplantation shows promise as a safe and effective treatment for congenital hematopoietic diseases, offering an alternative to postnatal bone marrow transplantation (BMT). Future research aims to improve engraftment and cell sourcing for broader clinical application.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fetal echocardiographic assessment of cardiovascular impact of prolonged support on EXTrauterine Environment for Neonatal Development (EXTEND) system.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2019
Same author

Physician views regarding the benefits and burdens of prenatal surgery for myelomeningocele.

Journal of perinatology : official journal of the California Perinatal Association·2017
Same author

Longitudinal neurodevelopmental and neuromotor outcome in congenital diaphragmatic hernia patients in the first 3 years of life.

Journal of perinatology : official journal of the California Perinatal Association·2013
Same author

Early gestational gene transfer with targeted ATP7B expression in the liver improves phenotype in a murine model of Wilson's disease.

Gene therapy·2011
Same author

Early intra-amniotic gene transfer using lentiviral vector improves skin blistering phenotype in a murine model of Herlitz junctional epidermolysis bullosa.

Gene therapy·2011
Same author

Jaagsiekte sheep retrovirus pseudotyped lentiviral vector-mediated gene transfer to fetal ovine lung.

Gene therapy·2011
Same journal

Bridging Science and Practice in Gender-Affirming Care: A Compendium for Gynecologists.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evidence, Clinical Expertise, and Research Gaps in Gender-Affirming Care.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evaluation and Management of the Pediatric Gender-Diverse Patient.

Obstetrics and gynecology clinics of North America·2026
Same journal

Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.

Obstetrics and gynecology clinics of North America·2026
Same journal

Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women.

Obstetrics and gynecology clinics of North America·2026
Same journal

Contraceptive Needs of the Transmasculine Patient.

Obstetrics and gynecology clinics of North America·2026
See all related articles

Area of Science:

  • Hematology
  • Transplantation Biology
  • Fetal Medicine

Background:

  • Congenital hematopoietic diseases currently rely on postnatal treatments like bone marrow transplantation (BMT).
  • Prenatal transplantation presents a potential alternative with significant clinical advantages.
  • Existing experimental and limited clinical data suggest feasibility and efficacy.

Observation:

  • * Experimental and limited clinical data suggest prenatal transplantation is viable.
  • * Challenges exist in optimizing in utero Hematopoietic Stem Cell (HSC) transplantation.
  • * Strategies are needed to enhance engraftment and ensure cell safety.

Findings:

  • * Prenatal HSC transplantation can potentially broaden reconstitution therapy indications.
  • * Improving engraftment and utilizing alternative cell sources are key experimental goals.

Related Experiment Videos

  • * Developing robust methods for cell procurement, ex vivo expansion, and banking is crucial.

    • Implications:

    • * Prenatal transplantation could become a safe, effective, and cost-efficient treatment.
    • * Identifying suitable recipients and establishing ethical guidelines are critical clinical steps.
    • * This approach holds promise for managing a range of congenital blood disorders.